Literature DB >> 23720345

Knockdown of parathyroid hormone related protein in smooth muscle cells alters renal hemodynamics but not blood pressure.

Denis Raison1, Catherine Coquard, Mazène Hochane, Jacques Steger, Thierry Massfelder, Bruno Moulin, Andrew C Karaplis, Daniel Metzger, Pierre Chambon, Jean-Jacques Helwig, Mariette Barthelmebs.   

Abstract

Parathyroid hormone-related protein (PTHrP) belongs to vasoactive factors that regulate blood pressure and renal hemodynamics both by reducing vascular tone and raising renin release. PTHrP is expressed in systemic and renal vasculature. Here, we wanted to assess the contribution of vascular smooth muscle cell endogenous PTHrP to the regulation of cardiovascular and renal functions. We generated a mouse strain (SMA-CreERT2/PTHrPL2/L2 or premutant PTHrPSM-/-), which allows temporally controlled, smooth muscle-targeted PTHrP knockdown in adult mice. Tamoxifen treatment induced efficient recombination of PTHrP-floxed alleles and decreased PTHrP expression in vascular and visceral smooth muscle cells of PTHrPSM-/- mice. Blood pressure remained unchanged in PTHrPSM-/- mice, but plasma renin concentration and creatinine clearance were reduced. Renal hemodynamics were further analyzed during clearance measurements in anesthetized mice. Conditional knockdown of PTHrP decreased renal plasma flow and glomerular filtration rate with concomitant reduction in filtration fraction. Similar measurements were repeated during acute saline volume expansion. Saline volume expansion induced a rise in renal plasma flow and reduced filtration fraction; both were blunted in PTHrPSM-/- mice leading to impaired diuresis. These findings show that endogenous vascular smooth muscle PTHrP controls renal hemodynamics under basal conditions, and it is an essential factor in renal vasodilation elicited by saline volume expansion.

Entities:  

Keywords:  blood pressure; parathyroid hormone-related protein; renal hemodynamics; saline volume expansion

Mesh:

Substances:

Year:  2013        PMID: 23720345     DOI: 10.1152/ajprenal.00503.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  4 in total

1.  Arteriosclerosis, bone biology, and calciotropic hormone signaling: learning the ABCs of disease in the bone-vascular axis.

Authors:  Dwight A Towler
Journal:  J Am Soc Nephrol       Date:  2014-09-17       Impact factor: 10.121

Review 2.  Nutrition in Cardioskeletal Health.

Authors:  Kathleen M Hill Gallant; Connie M Weaver; Dwight A Towler; Sowmyanarayanan V Thuppal; Regan L Bailey
Journal:  Adv Nutr       Date:  2016-05-16       Impact factor: 8.701

3.  Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide.

Authors:  Karim Sahbani; Christopher P Cardozo; William A Bauman; Hesham A Tawfeek
Journal:  Physiol Rep       Date:  2019-10

4.  Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial.

Authors:  Felicia Cosman; Linda R Peterson; Dwight A Towler; Bruce Mitlak; Yamei Wang; Steven R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.